Magnolia Neurosciences Corp
Biotechnology company · New York, United States
Magnolia Neurosciences Corp is a biotechnology company headquartered in New York, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $18 million sold in a notice filed in 2021.
Magnolia Neurosciences at a glance
What does Magnolia Neurosciences do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $18.4 million sold (2021).
Frequently asked questions about Magnolia Neurosciences
Where is Magnolia Neurosciences headquartered?
Magnolia Neurosciences Corp is headquartered in New York, United States.
What does Magnolia Neurosciences do?
Magnolia Neurosciences Corp is a biotechnology company.
When was Magnolia Neurosciences founded?
The earliest incorporation on record for Magnolia Neurosciences Corp is in 2018, according to public company registers.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences